Nawaz Sharif, Former PM of Pakistan, barred form holding office for life

Agencies

April 13, 2018

Islamabad, Apr 13: Pakistan's ousted prime minister Nawaz Sharif has been barred from holding office for life after the Supreme Court today ruled that disqualification of a lawmaker under the Constitution is for life.

The verdict was issued unanimously by all five judges of the bench while hearing a case related to the determination of time duration for disqualification of a lawmaker under the Constitution, the Dawn reported.

The court had grappled with Article 62(1)(f) which only stated that a lawmaker is disqualified under specified conditions but did not set out the duration of the disqualification.

Article 62, which sets the precondition for a member of parliament to be "sadiq and ameen" (honest and righteous), is the same provision under which Sharif, 68, was disqualified on July 28, 2017, in the Panama Papers case.

Likewise, Pakistan Tehreek-i-Insaf (PTI) leader Jahangir Tareen was disqualified on December 15 last year by a separate bench of the apex court under the same provision.

Following the verdict, both Sharif and Tareen have become ineligible to ever hold public office.

It has been stated in the decision read out by Justice Umar Ata Bandial that the disqualification of any member of parliament or a public servant under Article 62 in the future will be permanent.

Such a person cannot contest elections or become a member of parliament.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments